Domů › Rakovina endometria › Pennsylvania › Pittsburgh
Klinické studie Rakovina endometria v Pittsburgh, PA
23 studií pro Rakovina endometria hledá účastníky v lokalitách v Pittsburgh a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- a dalších 3
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
Probíhá nábor
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Probíhá náborFáze 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC Cancer Center-Washington, Washington · Vzdálenost 23 mi
- a dalších 1
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Probíhá náborFáze 1
- UPMC Hillman Cancer Center, Pittsburgh
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Probíhá náborFáze 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC-Mercy Hospital, Pittsburgh
- a dalších 12
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Probíhá náborFáze 1
- Research Site, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Probíhá náborFáze 1/2
- Allegheny Health Network, Pittsburgh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Probíhá náborFáze 1
- University of Pittsburgh Medical Center, Pittsburgh
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Probíhá náborFáze 3
- AHN West Penn Hospital ( Site 6006), Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Probíhá náborFáze 1/2
- Research Site, Pittsburgh
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Probíhá náborFáze 3
- Research Site, Pittsburgh
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Probíhá náborFáze 1
- UPMC Hillman Cancer Center, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Probíhá náborFáze 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Probíhá náborFáze 1
- UPMC, Pittsburgh
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Probíhá náborFáze 2
- West Penn Hospital, Pittsburgh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Probíhá náborFáze 1/2
- Allegheny Health Network, Pittsburgh
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Probíhá náborFáze 3
- Research Site, Pittsburgh
- Research Site, Pittsburgh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Probíhá náborFáze 2
- 127, Pittsburgh
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Probíhá náborFáze 2
- West Penn Allegheny Health, Pittsburgh
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Probíhá náborFáze 2
- West Penn Hospital, Pittsburgh
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Probíhá náborFáze 2
- Allegheny Health, Pittsburgh
Studie Rakovina endometria v jiných městech
- Houston, TX68 studií
- New York City, NY52 studií
- Boston, MA50 studií
- Arlington, VA39 studií
- Nashville, TN38 studií
- Los Angeles, CA34 studií
- St. Louis, MO29 studií
- Philadelphia, PA28 studií
- San Antonio, TX27 studií
- Chicago, IL25 studií
- Columbus, OH25 studií
- Queens, NY25 studií
Další studie v Pittsburgh
- Nemalobuněčný plicní karcinom48 studií
- Rakovina (všechny typy)41 studií
- Rakovina prsu39 studií
- Kolorektální karcinom32 studií
- Metastatický karcinom31 studií
- Melanom31 studií
- Rakovina vaječníků30 studií
- Rakovina plic23 studií
- Rakovina prostaty23 studií
- Mrtvice22 studií
- Squamózní buněčný karcinom hlavy a krku22 studií
- Deprese22 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.